Pirfenidone as a Radiosensitizer in the Treatment of Head and Neck Squamous Cell Carcinoma

NCT06142318 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

66

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Squamous Cell Carcinoma
Radiotherapy
Radiosensitizer
Pirfenidone

Interventions

DRUG: Pirfenidone
DRUG: Placebo

Sponsor

Nanfang Hospital, Southern Medical University